Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 22:12:e86002.
doi: 10.7554/eLife.86002.

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)

Collaborators, Affiliations
Review

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)

Zaki A Sherif et al. Elife. .

Abstract

COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional malaise, and cognitive dysfunction that last for months and impact everyday functioning, is referred to as Long COVID under the general category of post-acute sequelae of SARS-CoV-2 infection (PASC). PASC is highly heterogenous and may be associated with multisystem tissue damage/dysfunction including acute encephalitis, cardiopulmonary syndromes, fibrosis, hepatobiliary damages, gastrointestinal dysregulation, myocardial infarction, neuromuscular syndromes, neuropsychiatric disorders, pulmonary damage, renal failure, stroke, and vascular endothelial dysregulation. A better understanding of the pathophysiologic mechanisms underlying PASC is essential to guide prevention and treatment. This review addresses potential mechanisms and hypotheses that connect SARS-CoV-2 infection to long-term health consequences. Comparisons between PASC and other virus-initiated chronic syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome will be addressed. Aligning symptoms with other chronic syndromes and identifying potentially regulated common underlining pathways may be necessary for understanding the true nature of PASC. The discussed contributors to PASC symptoms include sequelae from acute SARS-CoV-2 injury to one or more organs, persistent reservoirs of the replicating virus or its remnants in several tissues, re-activation of latent pathogens such as Epstein-Barr and herpes viruses in COVID-19 immune-dysregulated tissue environment, SARS-CoV-2 interactions with host microbiome/virome communities, clotting/coagulation dysregulation, dysfunctional brainstem/vagus nerve signaling, dysautonomia or autonomic dysfunction, ongoing activity of primed immune cells, and autoimmunity due to molecular mimicry between pathogen and host proteins. The individualized nature of PASC symptoms suggests that different therapeutic approaches may be required to best manage specific patients.

Keywords: Long COVID; PASC; angiotensin-converting enzyme; epidemiology; global health; immunology; inflammation; pathobiological mechanisms; pathophysiological mechanisms; post-viral syndromes; tissue damage.

PubMed Disclaimer

Conflict of interest statement

ZS, CG, TC, TH, WR No competing interests declared

Figures

Figure 1.
Figure 1.. SARS-CoV-2’s entry into the respiratory system and its binding to ACE2 receptor produces a cascade of host responses ranging from chronic inflammation to endothelial dysregulation.

Similar articles

Cited by

References

    1. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. New England Journal of Medicine. 2020;383:120–128. doi: 10.1056/NEJMoa2015432. - DOI - PMC - PubMed
    1. Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. The Journal of Clinical Investigation. 2022;132:e161167. doi: 10.1172/JCI161167. - DOI - PMC - PubMed
    1. Aird WC. Phenotypic heterogeneity of the endothelium: II. representative vascular beds. Circulation Research. 2007;100:174–190. doi: 10.1161/01.RES.0000255690.03436.ae. - DOI - PubMed
    1. Akin C. Mast cell activation syndromes. The Journal of Allergy and Clinical Immunology. 2017;140:349–355. doi: 10.1016/j.jaci.2017.06.007. - DOI - PubMed
    1. Akpek M. Does COVID-19 cause hypertension? Angiology. 2022;73:682–687. doi: 10.1177/00033197211053903. - DOI - PMC - PubMed

Publication types